Your Article Summary
See Latest ArticlesProtective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort
Arthritis Care and Research , 06/03/09
Pons-Estel GJ et al. – Study demonstrates that after adjusting for possible confounding factors, the protective effect of hydroxychloroquine in retarding renal damage occurrence in systemic lupus erythematosus is still evident.
Methods- Aim was to assess whether hydroxychloroquine can delay renal damage development in lupus nephritis pts
- 256 pts; a multiethnic cohort of African Americans, Hispanics, and Caucasians; age: ≥16 yrs; disease duration: ≤5 yrs at baseline (T0)
- Renal damage was defined as ≥1 of the following lasting at least 6 mo:
- estimated/measured glomerular filtration rate <50%
- 24-hour proteinuria ≥3.5 gm and/or
- end-stage renal disease, regardless of dialysis or transplantation
- Pts with renal damage before T0 were excluded (n=53)
- Association between hydroxychloroquine use and renal damage was estimated using Cox proportional regression analyses adjusting for potential confounders
- Kaplan-Meier survival curves based on hydroxychloroquine intake or the WHO class glomerulonephritis were also derived
- 63/203 (31.0%) pts included developed renal damage over a mean disease duration of 5.2 yrs
- Most frequent renal damage domain item was proteinuria
- Pts who received hydroxychloroquine (79.3%) exhibited:
- a lower frequency of WHO class IV glomerulonephritis
- had lower disease activity, and
- received lower glucocorticoid doses
than those who did not take hydroxychloroquine
- After adjusting for confounders, hydroxychloroquine was protective of renal damage occurrence in full and reduced models
- Omitting proteinuria provided comparable results
- Cumulative probability of renal damage occurrence was higher in those:
- who did not take hydroxychloroquine and
- those classified as WHO class IV glomerulonephritis
Related Articles
Oxidative DNA damage in chronic renal failure patients
Nephrology Dialysis Transplantation, 11/05/09
Relevance Score: 69%
Intrarenal angiotensin II is associated with inflammation, renal damage, and dysfunction in Dahl salt-sensitive hypertension
Journal of the American Society of Hypertension, 10/15/09
Relevance Score: 68%
Mutagenicity of Immunosuppressive Medications among Renal Transplant Recipients
American Journal of Nephrology, 10/05/09
Relevance Score: 66%
The changing face of homozygous sickle cell disease: 102 patients over 60 years
International Journal of Laboratory Hematology, 10/28/09
Relevance Score: 65%
Rapid national survey of renal stones in New Zealand infants
Journal of Paediatrics and Child Health, 10/26/09
Relevance Score: 65%
Today in Chronic Dz/Renal Failure...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study
Atherosclerosis, 12/03/09
Fragility fractures in chronic kidney disease: An opinion-based approach
Cleveland Clinic Journal of Medicine, 12/03/09
Acute Kidney Injury in Critically Ill Patients with Cancer
Critical Care Clinics, 12/03/09
Today in Glomerular/Tubular Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis
Clinical and Experimental Immunology, 12/03/09
Rac1 Contributes to Actin Organization in Glomerular Podocytes
Nephron: Experimental Nephrology, 12/03/09
Early high-dose immunosuppression in Henoch-Schonlein nephrotic syndrome may improve outcome
Scandinavian Journal of Urology and Nephrology, 12/03/09